Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Iberdomide.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical pharmacology in drug development"
DOI: 10.1002/cpdd.1254
Abstract: Iberdomide is an orally available cereblon-modulating agent being developed for the treatment of hematologic malignancies and autoimmune-mediated diseases. To assess the potential concentration-QTc relationship in humans and to ascertain or exclude a potential QT effect… read more here.
Keywords: iberdomide; concentration; concentration qtc; analysis ... See more keywords